Ping Chi, MD, PhD
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, USA
Ping Chi is an Associate Member (Professor) in the Human Oncology and Pathogenesis Program (HOPP), and an Attending Physician in the Department of Medicine, Memorial Sloan Kettering Cancer Center (MSKCC). She is also an Associate Professor in the Department of Medicine, at Weill Cornell Medical College. She completed her MD/PhD training at the Weill Cornell/Rockefeller University/MSKCC tri-institutional MD/PhD program. She subsequently completed her clinical training in internal medicine at the Brigham and Woman’s Hospital, Harvard Medical School, and Medical Oncology Fellowship at MSKCC, as well as a concurrent postdoctoral training in epigenetics and chromatin biology in the C. David Allis’ lab at the Rockefeller University. Her current laboratory research focuses on understanding the genetic and epigenetic mechanisms of transcriptional activation of novel oncogenic transcripts and oncogenic transcription factors in solid tumor malignancies. Through mechanistic studies, she aims to identify novel therapeutic strategies to target oncogenic transcription factors and aberrant transcriptional activation of oncogenes. She also maintains an active academic clinical practice, leads early phase clinical trials and works with a multidisciplinary team to care for patients with melanoma and sarcomas, with the goal to expedite clinical translation of laboratory research.